Beijing Leadman Biochemistry Co.,Ltd. (SHE:300289)

SHE:300289 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	509.94	574.27	565.02	798.81	928.6	352.53
Trading Asset Securities	391.95	316.14	290.29	-	-	-
Cash & Short-Term Investments	901.88	890.41	855.32	798.81	928.6	352.53
Cash Growth	6.39%	4.10%	7.07%	-13.98%	163.41%	19.23%
Accounts Receivable	85.97	99.02	149.76	184.48	232.4	237.52
Other Receivables	13.79	19.56	2.4	6.05	5.67	7.87
Receivables	99.76	118.58	152.16	190.52	238.08	245.39
Inventory	88.33	89.45	88.28	97.44	102.48	78.91
Other Current Assets	17.43	8.71	9.93	23.73	9.96	11.27
Total Current Assets	1,107	1,107	1,106	1,111	1,279	688.1
Property, Plant & Equipment	395.5	402.3	427.68	458.68	474.96	575.94
Long-Term Investments	0.93	11.17	23.66	20.9	1.01	0.97
Goodwill	73.53	73.53	144.66	159.54	190.07	210.49
Other Intangible Assets	24.1	25.17	28.74	33.89	37.74	46.01
Long-Term Accounts Receivable	-	1.17	-	-	-	-
Long-Term Deferred Tax Assets	46.68	46.93	43.06	35.52	27.95	23.39
Long-Term Deferred Charges	10.19	12.02	17.23	24.56	26.15	8.75
Other Long-Term Assets	152.28	142.99	147.69	156.22	311.41	74.99
Total Assets	1,811	1,822	1,938	2,000	2,348	1,629
Accounts Payable	12.44	19.79	32.87	18.47	36.32	31.92
Accrued Expenses	1	8.21	17.56	31.34	25.8	23.5
Short-Term Debt	-	-	-	-	-	39.04
Current Portion of Leases	3.11	4.11	4.29	3.73	3.31	-
Current Income Taxes Payable	6.15	1.04	2.17	2	2.08	1.36
Current Unearned Revenue	8.15	10.27	10.86	7.91	8.2	8.37
Other Current Liabilities	39.96	37.78	38.63	89.57	103.49	58.7
Total Current Liabilities	70.81	81.2	106.38	153.01	179.21	162.88
Long-Term Leases	0.55	0.72	4.65	8.12	9.82	-
Long-Term Unearned Revenue	14.41	14.57	15.5	18.32	19.07	20.25
Long-Term Deferred Tax Liabilities	6.51	6.67	6.45	6.71	3.01	3.49
Other Long-Term Liabilities	0.68	0.68	0.79	33.19	159.19	63.3
Total Liabilities	92.96	103.84	133.77	219.35	370.3	249.92
Common Stock	544.01	544.01	544.01	544.01	544.01	421.05
Additional Paid-In Capital	610.81	610.81	610.81	610.81	651.39	242.74
Retained Earnings	506.02	507.28	587.82	572.48	639.63	617.21
Treasury Stock	-	-	-	-	-	-19.36
Total Common Equity	1,661	1,662	1,743	1,727	1,835	1,262
Minority Interest	56.82	56.48	61.99	53.16	143.08	117.07
Shareholders' Equity	1,718	1,719	1,805	1,780	1,978	1,379
Total Liabilities & Equity	1,811	1,822	1,938	2,000	2,348	1,629
Total Debt	3.66	4.83	8.95	11.84	13.13	39.04
Net Cash (Debt)	898.22	885.58	846.37	786.97	915.47	313.49
Net Cash Growth	6.95%	4.63%	7.55%	-14.04%	192.03%	26.67%
Net Cash Per Share	1.65	1.63	1.56	1.40	2.04	0.74
Filing Date Shares Outstanding	544.01	544.01	544.01	544.01	544.01	417.8
Total Common Shares Outstanding	544.01	544.01	544.01	544.01	544.01	417.8
Working Capital	1,037	1,026	999.3	957.49	1,100	525.22
Book Value Per Share	3.05	3.06	3.20	3.18	3.37	3.02
Tangible Book Value	1,563	1,563	1,569	1,534	1,607	1,005
Tangible Book Value Per Share	2.87	2.87	2.88	2.82	2.95	2.41
Buildings	-	486.27	495.09	488.24	487.72	595.27
Machinery	-	281.56	253.19	245.25	231.03	219.07
Construction In Progress	-	0.58	0.52	6.4	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.